PPARγ stimulation improves cardiovascular risk profile independent from its glucose lowering effects

被引：0
|
作者：
Hohberg, C
Lübben, G
Forst, T
Marx, N
Weber, MM
Löbig, M
Pfützner, A
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A149 / A150
页数：2
相关论文
共 50 条
  • [21] Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes
    Kalyani, Rita R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (13): : 1248 - 1260
  • [22] Glucose lowering does not necessarily reduce cardiovascular risk in type 2 diabetes
    Bourazana, Angeliki
    Giamouzis, Grigorios
    Skoularigis, John
    Triposkiadis, Filippos
    Xanthopoulos, Andrew
    WORLD JOURNAL OF CARDIOLOGY, 2022, 14 (04): : 266 - 270
  • [23] Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes
    Boussageon, Remy
    Maynie-Francois, Christine
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (07): : 670 - 670
  • [24] Determining When to Recommend Glucose-Lowering Drugs That Reduce Cardiovascular Risk
    Robertson, Sandy
    AMERICAN FAMILY PHYSICIAN, 2022, 105 (01) : 10 - 12
  • [25] From Treating Hypertension to Lowering Cardiovascular Disease Risk
    McCarthy, Cian P.
    Jackson, Rod
    McEvoy, John W.
    Rahimi, Kazem
    HYPERTENSION, 2024, 81 (08) : 1655 - 1658
  • [26] EFFECTS OF LOWERING ELEVATED LDL CHOLESTEROL ON THE CARDIOVASCULAR RISK OF LIPOPROTEIN(A)
    MAHER, VMG
    BROWN, BG
    MARCOVINA, SM
    HILLGER, LA
    ZHAO, XQ
    ALBERS, JJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (22): : 1771 - 1774
  • [27] Glucose metabolism and proinsulin intact level during an oral glucose load could be corrected by PPARγ-stimulation in non-diabetic patients at risk for cardiovascular events
    Forst, Thomas A.
    Karagiannis, Efstrathos
    Hohberg, Cloth
    Luebben, Georg
    Hanefeld, Markolf
    Weber, Matthias
    Pfuetzner, Andreas
    DIABETES, 2006, 55 : A571 - A571
  • [28] Hormone replacement therapy improves cardiovascular risk by lowering plasma viscosity in postmenopausal women
    Rosenson, RS
    Tangney, CC
    Mosca, LJ
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (12) : 1902 - 1905
  • [29] The metabolic and cardiovascular effects of hyperthyroidism are largely independent of β-adrenergic stimulation
    Bachman, ES
    Hampton, TG
    Dhillon, H
    Amende, I
    Wang, JF
    Morgan, JP
    Hollenberg, AN
    ENDOCRINOLOGY, 2004, 145 (06) : 2767 - 2774
  • [30] WITHDRAWAL OF CYCLOSPORINE IMPROVES THE CARDIOVASCULAR RISK PROFILE IN RENAL GRAFT RECIPIENTS
    IVENS, K
    HEERING, P
    WITHOLD, W
    KOCH, M
    REINAUER, H
    GRABENSEE, B
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 1013 - 1013
12345